The orange, round pill bearing the imprint Logo 66 is known to contain 0.5 mg of clonazepam. The provider is Advagen Pharma Ltd. Clonazepam is a member of the benzodiazepine anticonvulsant and benzodiazepine medication classes. It is used to treat Meniere’s disease, Epilepsy, Lennox-Gastaut syndrome, panic disorder, and seizure prevention. Positive evidence exists about human foetal risk throughout pregnancy. The Controlled Substance Act (CSA) lists 0.5 mg of clonazepam as a Schedule 4 controlled substance.
Accessible exclusively prescription Anticonvulsant drug class: benzodiazepines; pregnancy category D: positive indication of risk Schedule 4 of the CSA: Potential for Abuse Manufacturer/Vendor Adagen Pharma Ltd.
